Curatis Holding AG (XSWX:CURN) Tax Expense: CHF-0.11 Mil (TTM As of Dec. 2025)


XSWX:CURN Curatis Holding AG XSWX:CURN
33 GF Score
Price CHF23.60
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG Tax Expense?

Curatis Holding AG XSWX:CURN +3.51% 33 Tax Expense is CHF-0.11 Mil as of Dec. 2025. GuruFocus rates XSWX:CURN with a GF Score™ of 33/100. The stock has 7 warning signs investors should review.

Curatis Holding AG's tax expense for the months ended in Dec. 2025 was CHF0.02 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was CHF-0.11 Mil.


Curatis Holding AG  (XSWX:CURN) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Curatis Holding AG Tax Expense Related Terms


Curatis Holding AG Tax Expense Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Tax Expense Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
0.00 -5.16 -1.38 -0.29 -0.11

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.34 -0.07 -0.22 -0.13 0.02
XSWX:CURN
33GF Score
Curatis Holding AG XSWX:CURN
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of CHF-0.11 Mil mean?
Curatis Holding AG (XSWX:CURN) has a Tax Expense of CHF-0.11 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Curatis Holding AG and its competitors.
Is Curatis Holding AG's Tax Expense too high?
Curatis Holding AG's current Tax Expense is CHF-0.11 Mil. Overall, Curatis Holding AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Tax Expense compare to ZTS and UTHR?
Curatis Holding AG's Tax Expense of CHF-0.11 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Drug Manufacturers company?
A good Tax Expense depends on the Drug Manufacturers industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Curatis Holding AG and its competitors. Curatis Holding AG's current Tax Expense is CHF-0.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Tax Expense of CHF-0.11 Mil. The current Tax Expense is CHF-0.11 Mil. Curatis Holding AG's overall GF Score™ is 33/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Tax Expense is CHF-0.11 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
33GF Score

Get the complete analysis for XSWX:CURN

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.60
Price